Cargando…

Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome

BACKGROUND: Fetuin-A is a glycoprotein produced in the liver and related to metabolic syndrome; fetuin-A secretion is divergently regulated in different pathological conditions. In girls with polycystic ovary syndrome (PCOS), insulin sensitization results in a more favorable endocrine-metabolic outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Díaz, Marta, Gallego-Escuredo, José Miguel, López-Bermejo, Abel, de Zegher, Francis, Villarroya, Francesc, Ibáñez, Lourdes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6079549/ https://www.ncbi.nlm.nih.gov/pubmed/30123261 http://dx.doi.org/10.1155/2018/4192940

Ejemplares similares

Reduced circulating levels of chemokine CXCL14 in adolescent girls with polycystic ovary syndrome: normalization after insulin sensitization
por: García-Beltran, Cristina, et al.
Publicado: (2020)

MON-029 Polycystic Ovary Syndrome (PCOS) in Adolescent Girls:Toward a Simple On-Treatment Predictor of Post-Treatment Ovulation Rate
por: Ibanez, Lourdes, et al.
Publicado: (2020)

ODP426 SPIOMET4HEALTH: a 4-Arm Trial to Test the Effects of Lifestyle Intervention plus either Placebo, or Pioglitazone (PIO), or Spironolactone-Pioglitazone (SPIO), or Spironolactone-Pioglitazone-Metformin (SPIOMET) in Adolescent Girls and Young Women with PCOS
por: Ibanez, Lourdes, et al.
Publicado: (2022)

Toward a Treatment Normalizing Ovulation Rate in Adolescent Girls With Polycystic Ovary Syndrome
por: Ibáñez, Lourdes, et al.
Publicado: (2020)

OR25-3 Toward a Circulating Marker of Hepato-Visceral Fat Excess: S100A4 in Adolescent Girls with Polycystic Ovary Syndrome
por: Ibanez, Lourdes, et al.
Publicado: (2019)

FRI426 Raised Thyroid Stimulating Hormone In Girls With Polycystic Ovary SyndromeEffects Of Randomized Interventions
por: Ibanez, Lourdes, et al.
Publicado: (2023)

The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

Author Correction: The relative deficit of GDF15 in adolescent girls with PCOS can be changed into an abundance that reduces liver fat
por: de Zegher, Francis, et al.
Publicado: (2021)

A Single Nucleotide Polymorphism in STK11 Influences Insulin Sensitivity and Metformin Efficacy in Hyperinsulinemic Girls With Androgen Excess
por: López-Bermejo, Abel, et al.
Publicado: (2010)

SPIOMET4HEALTH—efficacy, tolerability and safety of lifestyle intervention plus a fixed dose combination of spironolactone, pioglitazone and metformin (SPIOMET) for adolescent girls and young women with polycystic ovary syndrome: study protocol for a multicentre, randomised, double-blind, placebo-controlled, four-arm, parallel-group, phase II clinical trial
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)

Metformin combined with spironolactone vs. metformin alone in polycystic ovary syndrome: a meta-analysis
por: Zeng, Huamin, et al.
Publicado: (2023)

Circulating exosomes decrease in size and increase in number between birth and age 7: relations to fetal growth and liver fat
por: Díaz, Marta, et al.
Publicado: (2023)

Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
por: Shahebrahimi, Karoon, et al.
Publicado: (2016)

Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
por: Vinaixa, Maria, et al.
Publicado: (2011)

PMON208 METFORMIN, SPIRONOLACTONE AND ORAL CONTRACEPTIVES IN POLYCYSTIC OVARY SYNDROME: A NETWORK META-ANALYSIS
por: Rodriguez-Gutierrez, Rene, et al.
Publicado: (2022)

Evaluating the effect of insulin sensitizers metformin and pioglitazone alone and in combination on women with polycystic ovary syndrome: An RCT
por: Sohrevardi, Seyed Mojtaba, et al.
Publicado: (2016)

Meteorin-like levels are associated with active brown adipose tissue in early infancy
por: Garcia-Beltran, Cristina, et al.
Publicado: (2023)

Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation
por: Kabiri, Nahid, et al.
Publicado: (2014)

Bone Morphogenetic Protein-8B Levels at Birth and in the First Year of Life: Relation to Metabolic-Endocrine Variables and Brown Adipose Tissue Activity
por: Garcia-Beltran, Cristina, et al.
Publicado: (2022)

Persisting benefits 12–18 months after discontinuation of pubertal metformin therapy in low birthweight girls
por: Ong, Ken, et al.
Publicado: (2007)

Associations of serum fetuin-A and oxidative stress parameters with polycystic ovary syndrome
por: Sak, Sibel, et al.
Publicado: (2018)

SAT376 Luteinizing Hormone Secretion in Hyperandrogenic Girls Taking Spironolactone or Metformin
por: Burt Solorzano, Christine Michele, et al.
Publicado: (2023)

Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research
por: Rani, Neha, et al.
Publicado: (2021)

Interaction between OCT1 and LPIN1 polymorphisms and response to pioglitazone-metformin tablets in patients with polycystic ovary syndrome
por: Zeng, Haixia, et al.
Publicado: (2023)

Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
por: Ochi, Akinobu, et al.
Publicado: (2014)

Effects of Low-Dose Spironolactone Combined with Metformin or Either Drug Alone on Insulin Resistance in Patients with Polycystic Ovary Syndrome: A Pilot Study
por: Long, Tao, et al.
Publicado: (2022)

Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome
por: Liu, Sha, et al.
Publicado: (2020)

Abundance of Circulating Preadipocyte Factor 1 in Early Life
por: de Zegher, Francis, et al.
Publicado: (2012)

Body Composition and Circulating High-Molecular-Weight Adiponectin and IGF-I in Infants Born Small for Gestational Age : Breast- Versus Formula-Feeding
por: de Zegher, Francis, et al.
Publicado: (2012)

On the rising incidence of early breast development: puberty as an adaptive escape from ectopic adiposity in mismatch girls
por: de Zegher, Francis, et al.
Publicado: (2021)

Fetuin-A and Its Association with Anthropometric, Atherogenic, and Biochemical Parameters and Indices among Women with Polycystic Ovary Syndrome
por: Kulik-Kupka, Karolina, et al.
Publicado: (2022)

Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials
por: Almalki, Hussain H., et al.
Publicado: (2020)

Pioglitazone Enhances Mitochondrial Biogenesis and Ribosomal Protein Biosynthesis in Skeletal Muscle in Polycystic Ovary Syndrome
por: Skov, Vibe, et al.
Publicado: (2008)

Pioglitazone Metformin Complex Improves Polycystic Ovary Syndrome Comorbid Psychological Distress via Inhibiting NLRP3 Inflammasome Activation: A Prospective Clinical Study
por: Guo, Qing-jun, et al.
Publicado: (2020)

Differential DNA methylation profile in infants born small-for-gestational-age: association with markers of adiposity and insulin resistance from birth to age 24 months
por: Diaz, Marta, et al.
Publicado: (2020)

Effects of metformin use in pregnant patients with polycystic ovary syndrome
por: Kumar, Pratap, et al.
Publicado: (2012)

Role of Metformin in Polycystic Ovary Syndrome (PCOS)-Related Infertility
por: Attia, Ghalia M, et al.
Publicado: (2023)

Predictive factors of polycystic ovary syndrome in girls with precocious pubarche
por: Guarnotta, Valentina, et al.
Publicado: (2021)

Circulating follistatin concentrations in adolescent PCOS: Divergent effects of randomized treatments
por: Díaz, Marta, et al.
Publicado: (2023)

Polycystic ovary syndrome and circulating inflammatory markers
por: Zafari Zangeneh, Farideh, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_to90otdprheog6r24h7pncb2q3